P

Inventor

JOHNSON DAVID SCOTT

US32 patents
⚠️ This page may combine multiple inventors who share the name “JOHNSON DAVID SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GIGAGEN INC

24 patents
US9738699B2Aug 22, 2017

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC9 citations91
US9422547B1Aug 23, 2016

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC11 citations91
US9695474B2Jul 4, 2017

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC8 citations83
US9926555B2Mar 27, 2018

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC5 citations82
US10329557B2Jun 25, 2019

Systems and methods for massively parallel combinatorial analysis of single cells

GIGAGEN INC9 citations81
US11053543B2Jul 6, 2021

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC1 citations72
US10787706B2Sep 29, 2020

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC1 citations72
US10465243B2Nov 5, 2019

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC1 citations72
US11702765B2Jul 18, 2023

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC1 citations71
US10689641B2Jun 23, 2020

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC2 citations71
US10214740B2Feb 26, 2019

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC1 citations71
US12241178B2Mar 4, 2025

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC0 citations61
US11591652B2Feb 28, 2023

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC0 citations61
US10106789B2Oct 23, 2018

System and methods for massively parallel analysis of nucleic acids in single cells

GIGAGEN INC1 citations61
US9926554B2Mar 27, 2018

Recombinant fusion proteins and libraries from immune cell repertoires

GIGAGEN INC1 citations61
US12195880B2Jan 14, 2025

Systems and methods for massively parallel combinatorial analysis of single cells

GIGAGEN INC0 citations60
US11441240B2Sep 13, 2022

Systems and methods for massively parallel combinatorial analysis of single cells

GIGAGEN INC0 citations60
US11427933B2Aug 30, 2022

Systems and methods for massively parallel combinatorial analysis of single cells

GIGAGEN INC0 citations60
US11111490B2Sep 7, 2021

Systems and methods for massively parallel combinatorial analysis of single cells

GIGAGEN INC0 citations60
US12421311B2Sep 23, 2025

Anti-CTLA-4 binding proteins and methods of use thereof

GIGAGEN INC1 citations58
US12404607B2Sep 2, 2025

Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

GIGAGEN INC0 citations55
US11685779B2Jun 27, 2023

Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

GIGAGEN INC0 citations55
US12590386B2Mar 31, 2026

Recombinant polyclonal proteins and methods of use thereof

GIGAGEN INC0 citations47
US11718660B2Aug 8, 2023

Recombinant polyclonal proteins targeting Zika and methods of use thereof

GIGAGEN INC0 citations44

MICROSOFT CORP

3 patents

GIGAMUNE INC

3 patents

RABINOWITZ MATTHEW

2 patents